loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 208653 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE (3)

filter

01 ZEVRA THERAP (3)

filter

01 TABLET;ORAL (3)

filter

01 325MG;EQ 4.08MG BASE (1)

02 325MG;EQ 6.12MG BASE (1)

03 325MG;EQ 8.16MG BASE (1)

filter

01 USA (3)

URL Supplier Web Content
TABLET;ORAL
325MG;EQ 8.16MG BASE
APADAZ
USA
208653
2019-01-04
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
325MG;EQ 6.12MG BASE
APADAZ
USA
208653
2018-02-23
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
325MG;EQ 4.08MG BASE
APADAZ
USA
208653
2019-01-04
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 208653

Looking for CTD TGA MCC DOSSIER APPLICATION 208653 3

19

Zevra Therapeutics, based in U.S.A, is a pharmaceutical company.

One of their notable products is ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE, with a corresponding application number 208653 and regulatory information .

proudly manufactured in the

approval since 2019-01-04

Zevra Therapeutics's APADAZ TABLET;ORAL, medication with 325MG;EQ 8.16MG BASE of ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE.

18

Zevra Therapeutics, based in U.S.A, is a pharmaceutical company.

One of their notable products is ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE, with a corresponding application number 208653 and regulatory information .

proudly manufactured in the

approval since 2018-02-23

Zevra Therapeutics's APADAZ TABLET;ORAL, medication with 325MG;EQ 6.12MG BASE of ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE.

17

Zevra Therapeutics, based in U.S.A, is a pharmaceutical company.

One of their notable products is ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE, with a corresponding application number 208653 and regulatory information .

proudly manufactured in the

approval since 2019-01-04

Zevra Therapeutics's APADAZ TABLET;ORAL, medication with 325MG;EQ 4.08MG BASE of ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE.

Post Enquiry
POST ENQUIRY